Open Access, Peer-reviewed
pISSN 2005-0380   eISSN 2005-0399
  1. ▸ KSGO 2024
  2. ▸ JSGO 2024
  3. ▸ ASGO 2023
  4. ▸ ASGO Webinar Series
    5.
  5. ▸ Journal Club
    6.
Current Issue  May 2024 • vol. 35 no. 3
More
Original Article
Cervix
Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance
Kim H, Kim KY, Kim D, Hwang JH.
Article   |   PDF
Original Article
Cervix
Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study
Wang Y, Lyu Y, Che X, Li J, Feng W.
Article   |   PDF
Original Article
Uterine Corpus
The automatic diagnosis artificial intelligence system for preoperative magnetic resonance imaging of uterine sarcoma
Toyohara Y, Sone K, Noda K, Yoshida K, Kato S, Kaiume M, et al.
Article   |   PDF
Original Article
Uterine Corpus
Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia
Lv X, Guo L, Wang C.
Article   |   PDF
Original Article
Uterine Corpus
Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan
Lee YY, Lai YL, Kim MS, Chang K, Kim HS, Cheng WF, et al.
Article   |   PDF
Original Article
Uterine Corpus
Development and validation of a novel scoring system to predict the risk of uterine perforation during intracavitary brachytherapy for cervical cancer
M Parvath ES, John NO, Sathyamurthy A, Ramireddy JK, Ram TS.
Article   |   PDF
Editor's Choice
Most Cited
•
Advances in diagnosis and treatment of metastatic cervical cancer
•
Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
•
Epidemiology of gynecologic cancers in China
•
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
•
FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
•
Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer
Journal Metrics
Year